Submitted by Anonymous (not verified) on 15 July 2024 - 13:55
Human medicines European public assessment report (EPAR): Dupixent, dupilumab, Date of authorisation: 26/09/2017, Revision: 35, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Dupixent, dupilumab, Date of authorisation: 26/09/2017, Revision: 35, Status: Authorised